This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Andrew Douglas, chief data and analytics officer at Forian Inc. FORA, joined a five-member panel at the Benzinga 2022 Cannabis Capital Conference to discuss the complexities of cannabis legalization and how important access is for patients and consumers who deserve so much more.
Forian optimizes the operational, clinical and financial performance for healthcare, cannabis and the government sector, providing businesses with innovative software solutions, proprietary data and predictive analytics technologies.
Other members of the panel included:
- Nick Kovacevich, CEO of Greenlane Holdings GNLN
- Vahan Ajamian, CPA, CA, CFA, Capital Markets Advisor of High Tide Inc HITI
- Greg Stolowitz, VP Corp Dev and IR of WM Technology Inc MAPS
- Moderator: David Feldman, Co-Founder and CEO of Skip Intro Advisors, LLC.
Watch the full panel discussion below:
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!